Ipamorelin: selective GHS-R1a agonist minimal cortisol, prolactin, or appetite effects GHRP-6: GHS-R1a agonist with additional CRH/ACTH activation, prolactin release, and potent orexigenic activity Ipamorelin selectivity ratio (GH:cortisol) is among the highest of all synthetic GHRPs GHRP-6 was instrumental in GHS-R1a receptor identification but is pharmacologically non-selective GH Release Profiles & Pulse Amplitude Both ipamorelin and GHRP-6 stimulate pulsatile GH release from anterior pituitary somatotrophs via GHS-R1a activation, working synergistically with endogenous GHRH
See what else we are up to on Instagram, X (Twitter), BluSky, Threads, LinkedIn, Facebook, YouTube and our website, DNAToday.com
Within this page, we will talk through a summary of key insights, with more detailed data an insights available in the linked sections below
It is widely distributed in the cells of mammals, plants and microorganisms
They can produce topical and other non-injectable preparations
SeekPeptides members access detailed protocol tracking tools and personalized guidance for managing GLP-1 side effects